201 related articles for article (PubMed ID: 38532749)
21. The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status.
Vargas-Robles D; Romaguera J; Alvarado-Velez I; Tosado-Rodríguez E; Dominicci-Maura A; Sanchez M; Wiggin KJ; Martinez-Ferrer M; Gilbert JA; Forney LJ; Godoy-Vitorino F
mSystems; 2023 Aug; 8(4):e0035723. PubMed ID: 37534938
[TBL] [Abstract][Full Text] [Related]
22. Correlation of High-Risk HPV Genotypes with Pap Test Findings: A Retrospective Study in Eastern Province, Saudi Arabia.
Kussaibi H; Al Dossary R; Ahmed A; Muammar A; Aljohani R
Acta Cytol; 2021; 65(1):48-55. PubMed ID: 32784299
[TBL] [Abstract][Full Text] [Related]
23. Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer
Yang Y; Zhu J; Feng R; Han M; Chen F; Hu Y
PeerJ; 2024; 12():e17415. PubMed ID: 38881859
[TBL] [Abstract][Full Text] [Related]
24. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies.
Molina MA; Coenen BA; Leenders WPJ; Andralojc KM; Huynen MA; Melchers WJG
mBio; 2022 Oct; 13(5):e0161922. PubMed ID: 35980030
[TBL] [Abstract][Full Text] [Related]
26. The Complex Interplay between Vaginal Microbiota, HPV Infection, and Immunological Microenvironment in Cervical Intraepithelial Neoplasia: A Literature Review.
Gardella B; Pasquali MF; La Verde M; Cianci S; Torella M; Dominoni M
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806188
[TBL] [Abstract][Full Text] [Related]
27. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.
Łaniewski P; Barnes D; Goulder A; Cui H; Roe DJ; Chase DM; Herbst-Kralovetz MM
Sci Rep; 2018 May; 8(1):7593. PubMed ID: 29765068
[TBL] [Abstract][Full Text] [Related]
28. Vaginal microbiome and cervical cancer.
Kyrgiou M; Moscicki AB
Semin Cancer Biol; 2022 Nov; 86(Pt 3):189-198. PubMed ID: 35276341
[TBL] [Abstract][Full Text] [Related]
29. Microbiota and HPV: The role of viral infection on vaginal microbiota.
Santella B; Schettino MT; Franci G; De Franciscis P; Colacurci N; Schiattarella A; Galdiero M
J Med Virol; 2022 Sep; 94(9):4478-4484. PubMed ID: 35527233
[TBL] [Abstract][Full Text] [Related]
30. Relationship between Papillomavirus vaccine, vaginal microbiome, and local cytokine response: an exploratory research.
Giraldo PC; Sanches JM; Sparvolli LG; Amaral R; Migliorini I; Gil CD; Taddei CR; Witkin SS; Discacciati MG
Braz J Microbiol; 2021 Dec; 52(4):2363-2371. PubMed ID: 34628621
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with the composition and diversity of the cervical microbiota of reproductive-age Black South African women: a retrospective cross-sectional study.
Onywera H; Williamson AL; Mbulawa ZZA; Coetzee D; Meiring TL
PeerJ; 2019; 7():e7488. PubMed ID: 31435492
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity.
Zhai Q; Zhang W; Zhang Z; Fu Y; Li Y; Wang X; Li L; Meng Y
Pol J Microbiol; 2021 Dec; 70(4):489-500. PubMed ID: 34970317
[TBL] [Abstract][Full Text] [Related]
33. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.
Norenhag J; Du J; Olovsson M; Verstraelen H; Engstrand L; Brusselaers N
BJOG; 2020 Jan; 127(2):171-180. PubMed ID: 31237400
[TBL] [Abstract][Full Text] [Related]
34. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
35. Vaginal Microbiota and Cytokine Microenvironment in HPV Clearance/Persistence in Women Surgically Treated for Cervical Intraepithelial Neoplasia: An Observational Prospective Study.
Caselli E; D'Accolti M; Santi E; Soffritti I; Conzadori S; Mazzacane S; Greco P; Contini C; Bonaccorsi G
Front Cell Infect Microbiol; 2020; 10():540900. PubMed ID: 33251154
[TBL] [Abstract][Full Text] [Related]
36. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection.
Chao XP; Sun TT; Wang S; Fan QB; Shi HH; Zhu L; Lang JH
Int J Gynecol Cancer; 2019 Jan; 29(1):28-34. PubMed ID: 30640680
[TBL] [Abstract][Full Text] [Related]
37. Repeat cytology and human papillomavirus screening strategies in detecting preinvasive cervical lesions.
Li K; Yin R
Medicine (Baltimore); 2015 Feb; 94(5):e435. PubMed ID: 25654377
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Triage for Atypical Squamous Cells of Undetermined Significance with Human Papillomavirus Testing in Cervical Cancer Screening in Japan.
Fujiwara H; Suzuki M; Morisawa H; Sayama M; Kimura K
Asian Pac J Cancer Prev; 2019 Jan; 20(1):81-85. PubMed ID: 30678384
[TBL] [Abstract][Full Text] [Related]
39. Cervical Human Papillomavirus genotypes in HIV-infected women: a cross-sectional analysis of the VALHIDATE study.
Orlando G; Bianchi S; Fasolo MM; Mazza F; Frati ER; Rizzardini G; Matteelli A; Zanchetta N; Amendola A; Tanzi E
J Prev Med Hyg; 2017 Dec; 58(4):E259-E265. PubMed ID: 29707656
[TBL] [Abstract][Full Text] [Related]
40. Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies.
Głowienka-Stodolak M; Bagińska-Drabiuk K; Szubert S; Hennig EE; Horala A; Dąbrowska M; Micek M; Ciebiera M; Zeber-Lubecka N
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
